OBJECTIVE: The purpose of this article is to review the roles that MRI is expected to play in emerging minimally invasive focal ablative therapies for prostate cancer. CONCLUSION: MRI, in combination with biopsy, will impact patient selection for focal ablation by helping to localize clinically significant tumor foci. Also, some ablation procedures may be performed using real-time MRI guidance. In addition, MRI may be used for assessment of extent of necrosis shortly after therapy and for long-term surveillance for recurrent tumor.
OBJECTIVE: The purpose of this article is to review the roles that MRI is expected to play in emerging minimally invasive focal ablative therapies for prostate cancer. CONCLUSION: MRI, in combination with biopsy, will impact patient selection for focal ablation by helping to localize clinically significant tumor foci. Also, some ablation procedures may be performed using real-time MRI guidance. In addition, MRI may be used for assessment of extent of necrosis shortly after therapy and for long-term surveillance for recurrent tumor.
Authors: Geert J S Litjens; Henkjan J Huisman; Robin M Elliott; Natalie Nc Shih; Michael D Feldman; Satish Viswanath; Jurgen J Fütterer; Joyce G R Bomers; Anant Madabhushi Journal: J Med Imaging (Bellingham) Date: 2014-10-27
Authors: Clement Orczyk; Artem Mikheev; Andrew B Rosenkrantz; Jonathan Melamed; Samir S Taneja; Henry Rusinek Journal: Proc SPIE Int Soc Opt Eng Date: 2012-02-23
Authors: Andreas M Hötker; Andreas Meier; Yousef Mazaheri; Junting Zheng; Marinela Capanu; Joshua Chaim; Ramon Sosa; Jonathan Coleman; Hedvig Hricak; Oguz Akin Journal: Abdom Radiol (NY) Date: 2019-01
Authors: Satish Viswanath; Robert Toth; Mirabela Rusu; Dan Sperling; Herbert Lepor; Jurgen Futterer; Anant Madabhushi Journal: Proc SPIE Int Soc Opt Eng Date: 2013-03-15